🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tanti spunti da Panorama Diabete e tante soddisfazioni per i nostri giovani ricercatori Luca Sacchetta premio Umberto Di Mario e Lorenzo Nesti premio Galeno 🏆🏆🏆 SID Italia

Thrilled to share new data on #amyloidosis diagnosis with global experts at #ISA2024! Fantastic organization by The International Society Of Amyloidosis Mayo Amyloid

Italians do it better!!!!!!

📢 Join us on Sept 19th for a webinar presented by the #CVSN SCILL Committee! Explore the "Role and Impact of a Patient-Centered Approach in Cardiovascular Disease." Don't miss this insightful discussion. Register now: t.ly/PB2Ak

Clinical and prognostic significance of central and obstructive apneas in patients with transthyretin cardiac amyloidosis academic.oup.com/eurjpc/article… ❤️

🚨🚨 Hot off the press! Thrilled to share our latest study on the clinical and prognostic significance of central and obstructive #apneas in patients with transthyretin cardiac #amyloidosis ➡️ lnkd.in/eztKtwtC #EJPC European Society of Cardiology Journals European Society of Cardiology ScuolaSantAnna

PhD Day in progress!!! Vinicio Guedes

News from PhD day in Translational Medicine at ScuolaSantAnna . Best clinical presentation to Vincenzo Castiglione and Best preclinical presentation to Francesca Salani. Very proud of you!

sciencedirect.com/science/articl…

Hi guys please join the meeting on proteomics in cardiac amiloydosis Pisa November 8 2024 @GiusVerg us02web.zoom.us/webinar/regist…

Supernice meeting today in Pisa on Proteomics in #cardiacamyloidosis Special thanks to the faculty and to our international guests Ahmad Masri Diana Canetti Ellen McPhail Michele Emdin Alberto Aimo Castiglione

🔴 Cardiac Amyloidosis: Role of the Endomyocardial Biopsy #CardioEd #Cardiology #Amyloidosis

18F-florbetaben PET imaging offers valuable prognostic information in AL-CA. Values of late (50’-60’) Total amyloid burden (i.e. mean standardized uptake value x molecular volume) measured in the LV and RV are strong predictors of all-cause mortality. ⁦Giuseppe Vergaro⁩

🔵 PET in cardiac amyloidosis: current evidence & future directions #Cardiology #CardioEd #FOAMed #Amyloidosis

Innovaciones en diagnostico y tratamiento de #amyloidosis cardiaca 1️⃣ Radiotrazadores PET ( 11C-PiB, 18F-flutemetamol, 18F-florbetapir, 18F-florbetaben, 18F-NaF) para identificar subtipos de amiloide, cuantificar carga y monitorizar progresión. bit.ly/41tYigv

Scuola Sant’Anna 7 e 8 aprile Heartsbolism

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

🔴PET in cardiac amyloidosis: current evidence & future directions ⤵️ #2025Review #OpenAccess 🔹link.springer.com/article/10.100… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter